US IPO Pipeline SEC S-1 Filings — May 28, 2026

IPO Pipeline

By Gunpowder Editorial ·

4 high priority 4 total filings analysed

Executive Summary

The IPO pipeline on May 28, 2026, presents a bifurcated landscape: two legitimate growth-oriented filings (Entrata and GridAI) alongside two speculative or distressed situations (Youmi and the Peach State merger).

Entrata's S-1 signals a high-profile tech IPO with complex compensation structures tied to majority owner returns, while GridAI's registration for warrant resale reflects a post-reverse-merger transformation into AI infrastructure with zero revenue from its new platform. The Peach State merger (UCB S-4) introduces a traditional banking consolidation with a fixed exchange ratio and regulatory hurdles. Period-over-period comparisons are limited as most filers lack historical financial data, but GridAI's shift from biopharma to AI-data center energy optimization represents a dramatic pivot. Insider activity is absent across filings, but the lack of proceeds to issuing companies (GridAI, Youmi) raises capital structure concerns. The overall sentiment is cautious, with materiality scores uniformly high (8/10) due to the transformative nature of these events.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: S-1

Tracking the trend? Catch up on the prior US IPO Pipeline SEC S-1 Filings digest from May 27, 2026.

Investment Signals (10)

  • Entrata (NEUTRAL)

    Filed S-1 for IPO of Class A common stock; performance stock options tied to majority owner's rate of return could create misaligned incentives

  • GridAI (BEARISH)

    Zero revenue from new AI platform post-transformation; 6.2M shares registered for resale from warrant exercises, no proceeds to company

  • GridAI (NEUTRAL)

    Acquired Grid AI Corp. (Sept 2025) gaining 75% of AMPX UK Holdings; legacy Adrulipase program still active but no revenue disclosed

  • Merger with Peach State offers $31.75 cash or 0.8978 shares per Peach State share; 50% cash/50% stock proration creates arbitrage opportunity

  • Youmi (BEARISH)

    Incorporated Feb 2026, zero revenue, net loss of $906; selling shares at fixed $0.10 until OTCQB listing—highly speculative

  • Entrata (NEUTRAL)

    Subject to 1% excise tax on future stock repurchases under Inflation Reduction Act; could limit buyback flexibility post-IPO

  • GridAI (BEARISH)

    1-for-3 reverse stock split (Aug 2025) applied retroactively; signals prior distress and potential dilution management

  • Tax-free reorganization condition under Section 368(a) adds execution risk; regulatory approvals needed from Fed and SCBFI

  • Youmi (BEARISH)

    Relies on single franchise agreement with convenience store operator in China; no employees or offices in China—operational risk

  • GridAI (BEARISH)

    Name/ticker change from ENTO to GRDX (Dec 2025) reflects pivot; warrants from May 2026 private placements could dilute if exercised

Risk Flags (10)

  • Performance stock options vest based on majority owner's rate of return, not company performance—potential governance issue

  • No revenue from AI platform post-acquisition; legacy biopharma program (Adrulipase) also pre-revenue—dual cash burn

  • Zero revenue since inception (Feb 2026), $906 net loss, $70K liabilities vs $202K assets—going concern risk

  • Merger requires Fed and SCBFI approval; any delay could impact deal timeline and stock price

  • 6.2M shares registered for resale from warrant exercises; if exercised, significant dilution to existing shareholders

  • Entrata/Tax Risk [MEDIUM RISK]

    OECD 'side-by-side' package (Jan 2026) exempts U.S. multinationals from global 15% minimum tax—but future changes could impact

  • Youmi/Market Risk [HIGH RISK]

    No public market for stock; fixed $0.10 price until OTCQB listing—liquidity risk and potential price manipulation

  • Merger integration could disrupt operations; no financial data in S-4 to assess combined entity health

  • Independent auditor not required to attest to internal controls as emerging growth company—restatement risk

  • 1% excise tax on stock repurchases under Inflation Reduction Act could deter buybacks post-IPO

Opportunities (10)

  • Merger consideration offers $31.75 cash or 0.8978 UCB shares; 50% cash/50% stock proration creates potential spread if UCB stock fluctuates

  • GridAI/AI Infrastructure Play (SPECULATIVE OPPORTUNITY)

    Acquired Grid AI Corp for AI-data center energy optimization; if successful, could capitalize on growing AI energy demand

  • Entrata/IPO Valuation (OPPORTUNITY)

    Filing reveals performance stock options tied to majority owner returns—could indicate aggressive valuation; watch for pricing

  • Youmi/OTCQB Listing (SPECULATIVE OPPORTUNITY)

    Fixed $0.10 price until OTCQB listing; if business gains traction, early investors could see gains—high risk/reward

  • Merger creates larger regional bank; potential cost synergies and improved market position

  • GridAI/Warrant Exercise (SPECULATIVE OPPORTUNITY)

    If warrants from May 2026 private placements are exercised, company receives proceeds—potential capital infusion

  • Entrata/IPO Timing (OPPORTUNITY)

    Filing on May 28, 2026; if market conditions favorable, could attract strong demand given property tech focus

  • Merger qualifies as tax-free reorganization under Section 368(a)—tax-efficient for Peach State shareholders

  • GridAI/Legacy Biopharma (SPECULATIVE OPPORTUNITY)

    Adrulipase program still active; if successful, could provide revenue stream alongside AI platform

  • Youmi/China Franchise (SPECULATIVE OPPORTUNITY)

    Single franchise agreement with convenience store operator in China; if expanded, could generate first revenue

Sector Themes (6)

  • AI Infrastructure Pivot

    GridAI's transformation from biopharma to AI-data center energy optimization reflects broader trend of legacy companies rebranding to capture AI demand—but zero revenue raises skepticism

  • IPO Pipeline Divergence

    Two IPOs (Entrata, GridAI) vs two resale registrations (Youmi, GridAI warrants) highlight split between growth capital raises and secondary distributions

  • Banking Consolidation

    United Community Banks' merger with Peach State continues regional bank consolidation trend; tax-free structures and regulatory approvals remain key hurdles

  • Speculative Micro-Caps

    Youmi's $202K assets and zero revenue typify early-stage micro-cap filings; fixed-price resale until OTCQB listing suggests limited institutional interest

  • Governance Concerns

    Entrata's performance stock options tied to majority owner returns (not company performance) raises governance red flags for IPO investors

  • Regulatory Overhang

    OECD tax rules (Entrata) and Inflation Reduction Act excise tax (Entrata) show regulatory factors impacting IPO structures and post-IPO capital allocation

Watch List (8)

  • Watch for IPO price range and valuation; performance stock options tied to majority owner returns could signal aggressive pricing

  • Monitor if warrants from May 2026 private placements are exercised; 6.2M shares could hit market, causing dilution

  • Watch for shareholder vote and regulatory approvals (Fed, SCBFI); any delay could impact deal spread

  • Monitor for OTCQB listing date; fixed $0.10 price will end, potentially leading to price discovery and volatility

  • Watch for first revenue from AI platform; zero revenue currently, any contract wins would be significant catalyst

  • Monitor if Entrata announces buyback plans post-IPO; 1% excise tax under Inflation Reduction Act could deter repurchases

  • Post-merger integration progress; watch for cost synergy targets and combined financials in future filings

  • Monitor franchise agreement expansion; single convenience store operator in China creates concentration risk

Filing Analyses (4)
ENTRATA, INC. S-1 neutral materiality 8/10

28-05-2026

Entrata, Inc. filed an S-1 registration statement with the SEC on May 28, 2026, for an initial public offering of its Class A common stock. The filing highlights significant risk factors including potential inaccuracies in operating metrics, complex tax issues, and the impact of stock-based compensation expenses. The company is an emerging growth company and its independent auditor is not required to attest to internal controls until after it ceases to be an emerging growth company.

  • · The filing discusses performance stock options that vest based on market conditions tied to the majority owner's rate of return.
  • · The company may be subject to a 1% excise tax on future stock repurchases under the Inflation Reduction Act.
  • · The OECD released a 'side-by-side' package on January 5, 2026, that generally exempts U.S. multinationals from the global 15% minimum tax.
  • · The company's operating metrics include number of units on its Operating System and ARPU, which may differ from third-party estimates.
GridAI Technologies Corp. S-1 mixed materiality 8/10

28-05-2026

GridAI Technologies Corp. (formerly Entero Therapeutics, Inc.) filed an S-1 registration statement on May 27, 2026 for the resale of up to 6,204,920 shares of common stock by selling stockholders. The shares are primarily issuable upon exercise of warrants from May 2026 private placements, and the company itself will receive no proceeds from the resale (only from warrant exercises). The company has transformed into a diversified technology and life sciences firm focused on AI-data center energy optimization (via Grid AI Corp.), while maintaining a legacy biopharmaceutical program (Adrulipase). It disposed of its ImmunogenX unit on Dec 31, 2025 and has no revenue from its new AI platform, carrying significant risks and high reliance on future development.

  • · GridAI acquired Grid AI Corp. on September 30, 2025, gaining 75% ownership of AMPX UK Holdings.
  • · Company name changed from Entero Therapeutics to GridAI Technologies on December 1, 2025; ticker changed from ENTO to GRDX.
  • · 1-for-3 reverse stock split effective August 18, 2025, applied retroactively to per share figures.
  • · ImmunogenX was disposed of on December 31, 2025, resulting in the discontinuation of Latiglutenase and CypCel programs.
  • · Company's legacy biopharmaceutical program (Adrulipase) continues, but no revenue is generated from the new AI data center platform.
  • · May 2026 private placements occurred under Securities Purchase Agreements dated May 8, 11, and 12, 2026.
  • · The S-1 also covers shares from pre-funded warrants and common warrants issued in those placements.
UNITED COMMUNITY BANKS INC S-4 neutral materiality 8/10

28-05-2026

United Community Banks Inc (UCB) filed an S-4 registration statement on May 28, 2026, for its merger with Peach State, where Peach State shareholders can elect to receive either $31.75 in cash or 0.8978 shares of UCB common stock per share, subject to proration such that 50% of Peach State shares will be converted into cash and 50% into stock. The filing highlights significant risks, including potential failure to qualify as a tax-free reorganization, regulatory approval delays, and integration challenges that could adversely affect the combined company's performance. No financial performance data is provided in this filing, so no period-over-period comparisons are available.

  • · The exchange ratio for stock consideration is 0.8978 shares of UCB common stock per Peach State share.
  • · The merger is conditioned on receipt of opinions from tax counsel that it qualifies as a 'reorganization' under Section 368(a) of the Internal Revenue Code.
  • · Regulatory approvals required include the Federal Reserve Board and the SCBFI (South Carolina Board of Financial Institutions).
  • · Peach State common stock is not listed on any exchange and has no established market.
  • · The filing incorporates by reference UCB's Annual Report on Form 10-K for the year ended December 31, 2025, filed February 17, 2026.
Youmi Inc. S-1 negative materiality 8/10

28-05-2026

Youmi Inc., a Nevada corporation incorporated in February 2026, filed an S-1 registration statement for the resale of up to 1,294,140 shares of common stock by selling stockholders at a fixed price of $0.10 per share until the stock is quoted on the OTCQB Venture Market. The company has not generated any revenue since inception (February 24, 2026 to April 30, 2026) and reported a net loss of $906, with total assets of $202,508 and total liabilities of $70,000. The business is in the early commercialization stage, relying on a single franchise agreement with a convenience store operator in China, and there is no public market for its stock.

  • · The company was incorporated on February 24, 2026, and has no subsidiaries, no VIE structure, and no offices or employees in China.
  • · The selling stockholders may sell shares at a fixed price of $0.10 per share until the stock is quoted on the OTCQB; thereafter, prices may vary.
  • · The company will not receive any proceeds from the resale of shares by selling stockholders.
  • · The company has only one franchise relationship, with an independent convenience store operator in China.
  • · The company's principal executive office is in Las Vegas, Nevada.
  • · The company qualifies as an 'emerging growth company' and a 'smaller reporting company'.

Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 4 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US IPO Pipeline SEC S-1 Filings

🇺🇸 More from United States

View all →